Our company pioneers an AI-driven platform that creates personalized digital replicas of individual health profiles. By integrating IoT devices and extensive data lakes, coupled with our AI-powered Digital Twin technology and MedAI Studio, we enable customizable real-time clinical model evolution. The platform includes HealthBot, an AI assistant, and operates on robust cloud and on-device architectures, targeting hospitals, insurance providers, genomic labs, and health-tech consumers. Currently, we seek $3 million in pre-launch funding, offering a 15% equity stake, to support an 18-month runway through late 2026. Launching in Q3 2025, we anticipate initial revenues by January 2026, scaling growth through SaaS subscriptions, clinical collaborations, and B2B licensing, with a sustainable business model poised to lead AI-powered preventive healthcare.